{
  "trial_id": "NCT01147250",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, body mass index (BMI), duration of type 2 diabetes, baseline HbA1c, history of hypertension, history of dyslipidemia, smoking status, prior myocardial infarction, prior stroke, baseline renal function (e.g., serum creatinine, estimated glomerular filtration rate), baseline urinary albumin/creatinine ratio, baseline use of cardiovascular medications (e.g., statins, beta-blockers, ACE inhibitors), baseline use of antidiabetic medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "gender"
        ],
        [
          "Race",
          "race"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "baseline HbA1c"
        ],
        [
          "Duration of Diabetes",
          "duration of type 2 diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity",
        "Qualifying Acute Coronary Syndrome (ACS) event",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "history of hypertension",
        "history of dyslipidemia",
        "smoking status",
        "prior myocardial infarction",
        "prior stroke",
        "baseline renal function (e.g., serum creatinine, estimated glomerular filtration rate)",
        "baseline urinary albumin/creatinine ratio",
        "baseline use of cardiovascular medications (e.g., statins, beta-blockers, ACE inhibitors)",
        "baseline use of antidiabetic medications"
      ]
    },
    "processed-gen-response": "Age, gender, race, body mass index (BMI), duration of type 2 diabetes, baseline HbA1c, history of hypertension, history of dyslipidemia, smoking status, prior myocardial infarction, prior stroke, baseline renal function (e.g., serum creatinine, estimated glomerular filtration rate), baseline urinary albumin/creatinine ratio, baseline use of cardiovascular medications (e.g., statins, beta-blockers, ACE inhibitors), baseline use of antidiabetic medications."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, History of Type 2 Diabetes, Baseline HbA1c, Body Mass Index, Blood Pressure, Cholesterol Levels, Smoking Status, Prior Cardiovascular Events, Renal Function (eGFR), Use of Cardiovascular Medications,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Sex: Female"
        ],
        [
          "Race",
          "Race/Ethnicity"
        ],
        [
          "Qualifying Acute Coronary Syndrome (ACS) event",
          "Prior Cardiovascular Events"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Duration of Diabetes",
          "History of Type 2 Diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Male",
        "Region of Enrollment",
        "Blood Pressure",
        "Cholesterol Levels",
        "Smoking Status",
        "Renal Function (eGFR)",
        "Use of Cardiovascular Medications"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, History of Type 2 Diabetes, Baseline HbA1c, Body Mass Index, Blood Pressure, Cholesterol Levels, Smoking Status, Prior Cardiovascular Events, Renal Function (eGFR), Use of Cardiovascular Medications"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes duration, Previous cardiovascular disease (CVD) event, Glycated hemoglobin, Blood pressure, Cholesterol, Triglycerides, Body Mass Index, History of smoking, History of hypertension, History of hyperlipidemia, History of chronic kidney disease, History of peripheral artery disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Sex: Female"
        ],
        [
          "Race",
          "Race/Ethnicity"
        ],
        [
          "Qualifying Acute Coronary Syndrome (ACS) event",
          "Previous cardiovascular disease (CVD) event"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "Glycated hemoglobin"
        ],
        [
          "Duration of Diabetes",
          "Diabetes duration"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "Male",
        "Region of Enrollment",
        "Blood pressure",
        "Cholesterol",
        "Triglycerides",
        "History of smoking",
        "History of hypertension",
        "History of hyperlipidemia",
        "History of chronic kidney disease",
        "History of peripheral artery disease"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes duration, Previous cardiovascular disease (CVD) event, Glycated hemoglobin, Blood pressure, Cholesterol, Triglycerides, Body Mass Index, History of smoking, History of hypertension, History of hyperlipidemia, History of chronic kidney disease, History of peripheral artery disease."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), systolic blood pressure, diastolic blood pressure, heart rate, smoking status, medical history (including history of hypertension, hyperlipidemia, and previous myocardial infarction), duration of type 2 diabetes, HbA1c, fasting plasma glucose, lipid profile, creatinine clearance, left ventricular ejection fraction, Killip class, cardiac biomarkers (Troponin, CK-MB), medication use (including antiplatelet agents, beta blockers, angiotensin-converting enzyme inhibitors, and statins).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "sex"
        ],
        [
          "Race",
          "race"
        ],
        [
          "Ethnicity",
          "ethnicity"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Glycosylated Hemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Duration of Diabetes",
          "duration of type 2 diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Qualifying Acute Coronary Syndrome (ACS) event",
        "Body Weight"
      ],
      "remaining_candidate_features": [
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "smoking status",
        "medical history (including history of hypertension, hyperlipidemia, and previous myocardial infarction)",
        "fasting plasma glucose",
        "lipid profile",
        "creatinine clearance",
        "left ventricular ejection fraction",
        "Killip class",
        "cardiac biomarkers (Troponin, CK-MB)",
        "medication use (including antiplatelet agents, beta blockers, angiotensin-converting enzyme inhibitors, and statins)"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), systolic blood pressure, diastolic blood pressure, heart rate, smoking status, medical history (including history of hypertension, hyperlipidemia, and previous myocardial infarction), duration of type 2 diabetes, HbA1c, fasting plasma glucose, lipid profile, creatinine clearance, left ventricular ejection fraction, Killip class, cardiac biomarkers (Troponin, CK-MB), medication use (including antiplatelet agents, beta blockers, angiotensin-converting enzyme inhibitors, and statins)."
  }
}